Found 7 matching trials
Study of E7777 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma and Cutaneous T-cell Lymphoma
PHASE2The purpose of this study is to evaluate the objective response rate (ORR) ...
Location
Eisai Trial Site #1
T-regulatory Cell Depletion With E7777 Combined With Pembrolizumab in Recurrent or Metastatic Solid Tumors
PHASE1Epithelial ovarian cancer (OC) is the most lethal gynecologic cancer: nearl...
Status
Active Not Recruiting
Location
UPMC Hillman Cancer Center
A Study of Remitoro in Participants With Recurrent or Refractory Peripheral T Cell Lymphoma and Cutaneous T Cell Lymphoma (All Case Study)
N/AThe primary purpose of the study is to investigate the incidence of adverse...
Location
Eisai Trial Site 3
A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma
PHASE3The purpose of this trial is to assess the efficacy of E7777 in participant...
Location
University of Alabama at Birmingham, Dermatology at Whitaker Clinic
A Phase 3 Trial of E7777 in Combination With CHOP Compared With CHOP Alone for the First-Line Treatment of Peripheral T-cell Lymphoma
PHASE3The purpose of this study is to evaluate whether treatment of E7777 in comb...
Location
Multiple Locations
E7777 for the Treatment of Patients With Peripheral T-Cell Lymphoma
PHASE1The purpose of this Phase 1 study is to determine the maximum tolerated dos...
Location
Multiple Locations
Ph I/II Study of E7777 Prior to CAR-T for R/R LBCL
PHASE1This is a multicenter Phase I study to determine the maximum tolerated dose...
Location
University of Minnesota, Masonic Cancer Center